Qube Research & Technologies LTD Haemonetics Corp Transaction History

Qube Research & Technologies LTD

$82.3 Billion
Q1 2025

A detailed history of Qube Research & Technologies LTD transactions in Haemonetics Corp stock. As of the latest transaction made, Qube Research & Technologies LTD holds 34,009 shares of HAE stock, worth $2.39 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

34,009

Previous 41,875 18.78%

Holding current value

$2.39 Million

Previous $3.27 Million 33.89%

% of portfolio

0.0%

Previous 0.0%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 15, 2025	SELL	$59.34 - $80.05 $466,768 - $629,673	-7,866 Reduced 18.78%	34,009 $2.16 Million
Q4 2024 Feb 14, 2025	BUY	$71.16 - $93.38 $2.98 Million - $3.91 Million	41,875 New	41,875 $3.27 Million
Q2 2024 Aug 14, 2024	BUY	$81.24 - $97.37 $3.5 Million - $4.2 Million	43,122 New	43,122 $3.57 Million
Q4 2023 Feb 13, 2024	BUY	$80.59 - $92.61 $3.43 Million - $3.94 Million	42,589 Added 76051.79%	42,645 $3.65 Million
Q3 2023 Nov 13, 2023	SELL	$82.56 - $93.49 $1.09 Million - $1.24 Million	-13,253 Reduced 99.58%	56 $5,000
Q2 2023 Aug 14, 2023	SELL	$80.84 - $89.45 $194,581 - $215,306	-2,407 Reduced 15.32%	13,309 $1.13 Million
Q1 2023 May 15, 2023	SELL	$72.75 - $90.6 $1.74 Million - $2.17 Million	-23,897 Reduced 60.33%	15,716 $1.3 Million
Q4 2022 Feb 14, 2023	BUY	$73.85 - $86.14 $1.13 Million - $1.32 Million	15,278 Added 62.78%	39,613 $3.12 Million
Q3 2022 Nov 14, 2022	BUY	$63.3 - $78.66 $42,094 - $52,308	665 Added 2.81%	24,335 $1.8 Million
Q2 2022 Aug 15, 2022	BUY	$49.27 - $66.08 $1.17 Million - $1.56 Million	23,670 New	23,670 $1.54 Million
Q2 2021 Aug 13, 2021	SELL	$51.81 - $118.56 $1.34 Million - $3.06 Million	-25,827 Closed	0 $0
Q1 2021 May 14, 2021	BUY	$111.01 - $139.48 $2.87 Million - $3.6 Million	25,827 New	25,827 $2.87 Million
Q3 2020 Nov 12, 2020	SELL	$75.65 - $93.58 $2.66 Million - $3.3 Million	-35,224 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$84.96 - $118.91 $2.99 Million - $4.19 Million	35,224 New	35,224 $3.16 Million
Q1 2020 May 15, 2020	SELL	$74.34 - $121.82 $145,260 - $238,036	-1,954 Closed	0 $0
Q4 2019 Feb 13, 2020	BUY	$114.37 - $129.46 $223,478 - $252,964	1,954 New	1,954 $225,000
Q3 2019 Nov 13, 2019	SELL	$117.16 - $138.52 $250,136 - $295,740	-2,135 Closed	0 $0
Q2 2019 Aug 02, 2019	BUY	$81.74 - $120.34 $174,514 - $256,925	2,135 New	2,135 $257,000
Q4 2018 Feb 14, 2019	SELL	$90.66 - $116.63 $157,295 - $202,353	-1,735 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$89.96 - $114.58 $116,408 - $148,266	1,294 Added 293.42%	1,735 $199,000
Q2 2018 Aug 14, 2018	BUY	$71.53 - $95.75 $31,544 - $42,225	441 New	441 $40,000

Others Institutions Holding HAE

# of Institutions

351

Shares Held

53.3M

Call Options Held

417K

Put Options Held

314K

View Full List

About HAEMONETICS CORP

Ticker HAE
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 51,316,500
Market Cap $3.61B
Description
Haemonetics Corporation, a healthcare company, provides medical products and solutions. It operates through three segments: Plasma, Blood Center, and Hospital. The company offers automated plasma collection devices, related disposables, and software, including NexSys PCS and PCS2 plasmapheresis equipment and related disposables and intravenous s...

More about HAE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Qube Research & Technologies LTD, based on Form 13F filings with the SEC.

News

Stay updated on Qube Research & Technologies LTD with notifications on news.

Account

Qube Research & Technologies LTD Haemonetics Corp Transaction History